These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. No association between apolipoprotein E polymorphisms and general cognitive ability in children. Turic D, Fisher PJ, Plomin R, Owen MJ. Neurosci Lett; 2001 Feb 16; 299(1-2):97-100. PubMed ID: 11166947 [Abstract] [Full Text] [Related]
3. Apolipoprotein E genotype and memory in the sixth decade of life. Schultz MR, Lyons MJ, Franz CE, Grant MD, Boake C, Jacobson KC, Xian H, Schellenberg GD, Eisen SA, Kremen WS. Neurology; 2008 May 06; 70(19 Pt 2):1771-7. PubMed ID: 18235080 [Abstract] [Full Text] [Related]
7. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Martins CA, Oulhaj A, de Jager CA, Williams JH. Neurology; 2005 Dec 27; 65(12):1888-93. PubMed ID: 16380608 [Abstract] [Full Text] [Related]
9. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder. Kerr DS, Stella F, Radanovic M, Aprahamian I, Bertollucci PH, Forlenza OV. Bipolar Disord; 2016 Feb 27; 18(1):71-7. PubMed ID: 26877211 [Abstract] [Full Text] [Related]
12. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R. Arch Neurol; 2005 Jun 27; 62(6):975-80. PubMed ID: 15956169 [Abstract] [Full Text] [Related]
14. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength. Batterham PJ, Bunce D, Cherbuin N, Christensen H. Am J Geriatr Psychiatry; 2013 Oct 27; 21(10):1010-9. PubMed ID: 23567378 [Abstract] [Full Text] [Related]
15. APOE genotype and cognitive change in young, middle-aged, and older adults living in the community. Bunce D, Bielak AA, Anstey KJ, Cherbuin N, Batterham PJ, Easteal S. J Gerontol A Biol Sci Med Sci; 2014 Apr 27; 69(4):379-86. PubMed ID: 23902936 [Abstract] [Full Text] [Related]
17. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype. Bracco L, Piccini C, Baccini M, Bessi V, Biancucci F, Nacmias B, Bagnoli S, Sorbi S. Dement Geriatr Cogn Disord; 2007 Apr 27; 24(6):483-91. PubMed ID: 18025782 [Abstract] [Full Text] [Related]
18. Apolipoprotein E genotype and lifetime cognitive decline. Kozauer NA, Mielke MM, Chan GK, Rebok GW, Lyketsos CG. Int Psychogeriatr; 2008 Feb 27; 20(1):109-23. PubMed ID: 17711604 [Abstract] [Full Text] [Related]
19. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. Yip AG, Brayne C, Easton D, Rubinsztein DC, Medical Research Council Cognitive Function Ageing Study (MRC CFAS). J Med Genet; 2002 Sep 27; 39(9):639-43. PubMed ID: 12205106 [Abstract] [Full Text] [Related]
20. The effect of APOE genotype on clinical phenotype in Alzheimer disease. Borroni B, Di Luca M, Padovani A. Neurology; 2007 Feb 20; 68(8):624; author reply 624. PubMed ID: 17310043 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]